GPT-Rosalind vs GPT-5.6: OpenAI's life-sciences specialist against its own flagship family

GPT-Rosalind vs GPT-5.6 is the rare matchup where both models come from Open​AI — GPT-Rosalind, the life-sciences reasoning model that left research preview on September 11, 2026, and the GPT-5.6 family (Sol, Terra, Luna), the generalist flagship tiers released July 9, 2026. Rosalind lists at $5.00/$25.00 per 1M tokens effective October 5; the GPT-5.6 family spans $0.20/$1.20 (Luna) to $4.00/$20.00 (Sol) at base tier. This is the comparison most teams will actually face: Open​AI's own pricing forces the question of whether a specialized life-sciences model is worth a premium over the generalist that powers most production workloads.

The family tree

GPT-Rosalind is O​penAI's purpose-built life-sciences model, introduced April 16, 2026, named after Rosalind Franklin, and built for reasoning over molecules, proteins, genes, pathways, and disease-relevant biology with a 50+ tool plugin ecosystem. It launched to US trusted-access partners, expanded in June with GPT-5.5-class agentic coding, and on September 11, 2026 exited research preview into a global trusted-access program at $5.00/$25.00 per 1M tokens ($0.50 cached input), billing beginning October 5, 2026.

The GPT-5.6 family — flagship Sol, balanced Terra, and fast cost-efficient Luna — released July 9, 2026 as O​penAI's generalist workhorses: 1.05M-token context windows, up to 128K output tokens, text-and-image input, and tiered pricing by input token count. Luna runs $0.20/$1.20 per 1M tokens at base tier, Terra $2.00/$12.00, Sol $4.00/$20.00, each doubling past 272K input tokens.

The scoreboard

• Price — GPT-Rosalind $5.00 / $25.00 (cached input $0.50), effective Oct 5. GPT-5.6 Sol $4.00 / $20.00, Terra $2.00 / $12.00, Luna $0.20 / $1.20 (all base tier ≤272K; double above).

• AA Intelligence Index — GPT-5.6 Sol 47.1 (#7 of 141), Terra 42.3, Luna 37.5. GPT-Rosalind: not tracked on the general index.

• AA Coding — GPT-5.6 Sol 77.4 (#3 of 138), Terra 76.7, Luna 71.4. GPT-Rosalind: n/a — not a software model.

• Context window — All 1M+ tokens. GPT-5.6 up to 128K output; GPT-Rosalind undisclosed but tool-heavy.

• Access — GPT-5.6: open API to any account, on OrcaRouter at list price. GPT-Rosalind: trusted-access qualification.

• Domain evals — GPT-Rosalind: BixBench leading, 6/11 LABBench2 wins over GPT-5.4, +53.7% GeneBench, +18.0% MedChemBench, +19.6% LabWorkBench (vendor-reported). GPT-5.6: no published life-sciences suite.

What GPT-5.6 already does well

GPT-5.6 Sol is one of the best independently-verified general models available: 47.1 on the AA Intelligence Index (#7 of 141), 77.4 AA Coding (#3 of 138), 1.05M context, 128K output. It is O​penAI's answer for deep multi-step reasoning, large-scale software engineering, and long-horizon agentic workflows. Luna at $0.20/$1.20 is the cost-efficiency story — a model that retains genuinely capable reasoning for chat, classification, extraction, and lightweight agentic work at a price that makes high-volume deployment trivial. For any lab whose token spend is dominated by code, data pipelines, extraction, and general reasoning, the GPT-5.6 family is the proven, open-access, independently-scored default.

The honest gap: GPT-5.6's benchmark record is generalist. Sol scores 47.1 AA Intelligence, Terra 42.3, Luna 37.5 — all strong, none of it measuring cloning-protocol design, RNA-function prediction, or target prioritization. Nothing in the GPT-5.6 family has a published BixBench, LABBench2, or GeneBench result, because those are life-sciences evals. If your question is "can a generalist handle my biology," the answer is "it can handle the text, but it was never trained on the task."

What Rosalind adds on top

Rosalind is the domain-tuned layer above the same underlying capability. Its vendor-reported evals measure the biology-specific work the 5.6 family doesn't claim: leading BixBench, 6 of 11 LABBench2 tasks above GPT-5.4, per-token gains of 53.7% on GeneBench, 18.0% on MedChemBench, 19.6% on LabWorkBench. The Dyno Therapeutics result — 95th percentile of human experts on RNA-sequence prediction, best-of-ten — is the ceiling case. The Life Sciences Research Plugin is a concrete tooling edge: 50+ scientific tools and databases as composable skills in Codex.

But the premium over Luna is stark: $5.00/$25.00 against $0.20/$1.20 is 25x on input and roughly 21x on output. Even against Sol — the closest flagship at $4.00/$20.00 — Rosalind is 25% more expensive per token, and Sol is independently scored at 47.1 AA Intelligence while Rosalind's domain numbers are all vendor-reported. The premium is the price of specialization, and it is only defensible at the decisions where the specialist is actually used.

The premium, priced honestly

A high-throughput pipeline that burns most of its budget on extraction and screening should not run those tokens through a $25/M-output specialist. GPT-5.6 Luna at $0.20/$1.20 is the rational vehicle for volume, and its 37.5 AA Intelligence Index confirms it is not a toy. The premium belongs on the molecular-reasoning decisions — a target to prioritize, a variant to interpret, a protocol to design — where a domain-tuned model's accuracy is worth 25x the token cost, assuming it is more accurate, which the vendor's unpublished-by-third-parties numbers support but do not prove.

Routing the two tiers on one key

Because both halves of this comparison are routable in practice, the hybrid is the obvious architecture. GPT-5.6 Sol, Terra, and Luna are all on OrcaRouter at list price — $4.00/$20.00, $2.00/$12.00, $0.20/$1.20 per 1M, 0% markup, automatic failover, one API. Rosalind itself requires the direct trusted-access application, but the routing DSL already lets you compose the stack you actually want: Luna for high-volume extraction, Sol for deep agentic coding, a specialist endpoint for the biology decisions — each on its own routing rule, failover between providers, and vendor price cuts passed through the day they happen. O​penAI's own lineup, routed sensibly, is a two-tier stack: the GPT-5.6 family for everything, Rosalind for the moments that justify the premium.

Bottom line

GPT-Rosalind vs GPT-5.6 is not a contest between rivals; it is a question of whether to pay for specialization on top of a family you may already use. GPT-5.6 Sol, Terra, and Luna are independently verified, open-access, and cheap at the base tier — Luna especially. GPT-Rosalind is the purpose-built layer for life-sciences reasoning, with real domain evidence (vendor-reported), a real tool ecosystem, and a real access gate. Teams doing biological discovery should evaluate Rosalind for the decision points after clearing trusted access, and route the rest of their volume through the GPT-5.6 family on one key. The models are not substitutes; the premium is only worth paying where the specialization is actually used.